Curanex Pharmaceuticals Inc Gains 45.77%

Thu, Feb 26, 2026 at 07:27 PM

Curanex Pharmaceuticals Inc (CURX:NASDAQ) soared at $0.46, representing a gain of 45.8%. On Thu, Feb 26, 2026, CURX:NASDAQ hit a New 2-Week High of $0.46. The stock appeared on our News Catalysts scanner on Wed, Feb 25, 2026 at 11:42 AM in the 'INVESTOR UPDATE' category. From Fri, Feb 13, 2026, the stock recorded 50.00% Up Days and 33.33% Green Days

The stock spiked on Thu, Feb 26, 2026 at $0.67 with a volume of 206M+.

About Curanex Pharmaceuticals Inc (CURX:NASDAQ)

Curanex is a developmental stage pharmaceutical company dedicated to discovering, developing and commercializing innovative botanical drugs to treat patients suffering from inflammatory diseases.

Top 10 Gainers:

Avalon GloboCare Corp. (ALBT:NASDAQ), 114.48%
Antelope Enterprise Holdings Limited (AEHL:NASDAQ), 108.9%
Rackspace Technology, Inc. (RXT:NASDAQ), 68.89%
Butterfly Network, Inc. (BFLY:NYSE), 50.65%
LiveWire Group, Inc. (LVWR:NYSE), 47.17%
Megan Holdings Limited (MGN:NASDAQ), 46.34%
Curanex Pharmaceuticals Inc (CURX:NASDAQ), 45.77%
XCF Global Inc. (SAFX:NASDAQ), 44.08%
N2OFF, Inc. (NITO:NASDAQ), 38.64%
Sezzle Inc. (SEZL:NASDAQ), 35.26%